O=C(Nc1ccc(Cl)cc1)/C(Cc1cccc[n+]1[O-])=N\Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?